Abstract Parotid gland is a rare site of metastasis from gastrointestinal (GI) tract primary cancer. Here, we present an interesting case report parotid unknown with probable lower GI as cancer, normal colonoscopy and upper endoscopy. This highlights the importance immunohistochemistry in taking treatment decisions during dilemmatic situations.

objective(s): to review the findings of the patients with sjögren’s syndrome (ss) having technetium-99m-pertechnetate (99mtc-pertechnetate) and gallium-67 citrate (ga-67) salivary gland scintigraphy in the past eight years.methods: the patients with ss, who were referred to our department for salivary gland scintigraphy during january 2008-december 2015 were studied using both 99mtc-pertechneta...

Objective(s): To review the findings of the patients with Sjögren’s syndrome (SS) having technetium-99m-pertechnetate (99mTc-pertechnetate) and gallium-67 citrate (Ga-67) salivary gland scintigraphy in the past eight years.Methods: The patients with SS, who were referred to our department for salivary gland scintigraphy during January 2008-December 2015 were studied using both 99mTc-pertechneta...

Introduction: Background: Radiotherapy of parotid tumors is achieved by different radiotherapy techniques. So they deliver the dose to organs at risk such as contralateral parotid, temporal lobe & spinal cord. The consequences of high dose to OARs are xerostomia, Temporal lobe necrosis and loss of hearing. Purpose: The aim of this study was to compare different treatment tech...

Xerostomia (dry mouth), resulting from radiation damage to the parotid glands, is one of the most common and distressing side effects of head-and-neck cancer radiotherapy. Recent MRI studies have demonstrated that the volume reduction of parotid glands is an important indicator for radiation damage and xerostomia. In the clinic, parotid-volume evaluation is exclusively based on physicians' manu...

Salivary gland involvement is one of the radioiodine therapy complications. Salivary gland scintigraphy in quantitative mode can accurately evaluate salivary gland function. Methods: Salivary gland scintigraphy was performed with Tc-99m Pertechnetate, at the time of iodine therapy as a basic study and then 3 weeks and 3 months afterwards. Ejection Fraction (EF) of parotid and submandibula...

BACKGROUND Carcinoma ex pleomorphic adenoma (CXPA) of the parotid gland is a high-grade cancer and the prognosis of this cancer has not been compared with non-CXPA high-grade primary parotid cancer. METHODS Retrospective medical chart review of patients with surgically treated high-grade primary parotid cancer (21 CXPA and 52 non-CXPA) was performed with correlation with disease-specific surv...

  Introduction:  The use of radioactive iodine (131I) has become an important adjunct to the treatment of thyroid cancer and hyperthyroidism. Salivary gland has the ability to concentrate radioactive iodine under normal circumstances. Salivary gland dysfunction and dry mouth are the common side effectsof high-dose radioiodine therapy. The purposeof this stu...

Parotid gland cancer; 3DCRT; Postoperative radiotherapy techniques; Dose distribution Abstract Introduction: Postoperative radiotherapy of the parotid gland could be achieved with various radiotherapy techniques. However they irradiate differently the surrounding organs at risk (OARs) in particular the cochlea, oral cavity & contralateral parotid causing significant increase in the risk of oral...

Introduction: Salivary gland cancer is an uncommon malignancy in the head and neck. The most common histopathologic type salivary malignancies mucoepidermoid carcinoma (MEC). Radiotherapy has a role malignancy, especially inoperable cases postoperative settings. Definitive or radiotherapy with without chemotherapy can improve locoregional control (LRC) patients parotid carcinoma. Case Presentat...